AGP Picks
View all

Health Observer Falkland Islands
Provided by AGP

Health Observer Falkland Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Falkland Islands.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on June 12, 2026

Menstrual Cup Market to reach USD 1.62 Billion by 2035 at 4.91% CAGR
Jun. 12, 2026

Menstrual Cup Market to reach USD 1.62 Billion by 2035 at 4.91% CAGR

Indeterminate EIN Presswire
Pharmacy Automation Market to reach USD 17.34 Billion by 2035 at 9.32% CAGR
Jun. 12, 2026

Pharmacy Automation Market to reach USD 17.34 Billion by 2035 at 9.32% CAGR

Indeterminate EIN Presswire
Medical Coding Market to reach USD 68.54 Billion by 2035 at 10.14% CAGR
Jun. 12, 2026

Medical Coding Market to reach USD 68.54 Billion by 2035 at 10.14% CAGR

Indeterminate EIN Presswire
Demand for ALD Equipment Market is forecasted to reach a value of US $5.39 billion by 2030
Jun. 12, 2026

Demand for ALD Equipment Market is forecasted to reach a value of US $5.39 billion by 2030

Indeterminate EIN Presswire
Air Purifiers Market Set to Reach $5.07 Billion by 2030
Jun. 12, 2026

Air Purifiers Market Set to Reach $5.07 Billion by 2030

Indeterminate EIN Presswire
HorseWood Claims Evaluated: The Horse Gelatin Trick for Natural Male Enhancement Support
Jun. 12, 2026

HorseWood Claims Evaluated: The Horse Gelatin Trick for Natural Male Enhancement Support

Indeterminate GlobeNewswire
Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes
Jun. 12, 2026

Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes

Indeterminate GlobeNewswire
Communiqué de presse : Le Tzield de Sanofi approuvé aux États-Unis comme première thérapie modificatrice de la maladie pour les patients récemment diagnostiqués avec un diabète de type 1 au stade 3
Jun. 12, 2026

Communiqué de presse : Le Tzield de Sanofi approuvé aux États-Unis comme première thérapie modificatrice de la maladie pour les patients récemment diagnostiqués avec un diabète de type 1 au stade 3

Indeterminate GlobeNewswire
Avicanna Announces Closing of Non-Brokered Private Placement
Jun. 12, 2026

Avicanna Announces Closing of Non-Brokered Private Placement

Indeterminate GlobeNewswire
Traws Pharma Provides Regulatory Update on Influenza Program
Jun. 12, 2026

Traws Pharma Provides Regulatory Update on Influenza Program

Indeterminate GlobeNewswire
XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange
Jun. 12, 2026

XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange

Indeterminate GlobeNewswire
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun. 12, 2026

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
4DMT Announces New Employment Inducement Grants
Jun. 12, 2026

4DMT Announces New Employment Inducement Grants

Indeterminate GlobeNewswire
Cartesian Therapeutics Announces New Employment Inducement Grant
Jun. 12, 2026

Cartesian Therapeutics Announces New Employment Inducement Grant

Indeterminate GlobeNewswire
XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date
Jun. 12, 2026

XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date

Indeterminate GlobeNewswire
Rhythm Pharmaceuticals to Announce Interim Six-Month Phase 2 Results Evaluating Setmelanotide in Patients with Prader-Willi Syndrome
Jun. 12, 2026

Rhythm Pharmaceuticals to Announce Interim Six-Month Phase 2 Results Evaluating Setmelanotide in Patients with Prader-Willi Syndrome

Indeterminate GlobeNewswire
Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines
Jun. 12, 2026

Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines

Indeterminate GlobeNewswire
SL BIO Ltd. and Horizon Space Acquisition II Announce Closing of Business Combination and Listing on the Nasdaq Global Market
Jun. 12, 2026

SL BIO Ltd. and Horizon Space Acquisition II Announce Closing of Business Combination and Listing on the Nasdaq Global Market

Indeterminate GlobeNewswire
MedPro Healthcare Staffing Sponsors First-Ever Graduation Celebration for Long-Term Patients at Joe DiMaggio Children's Hospital
Jun. 12, 2026

MedPro Healthcare Staffing Sponsors First-Ever Graduation Celebration for Long-Term Patients at Joe DiMaggio Children's Hospital

Indeterminate GlobeNewswire
Exploratory Efficacy Data Suggests Further Study of Peanut Tolerance with Oral Mucosal Immunotherapy (OMIT)
Jun. 12, 2026

Exploratory Efficacy Data Suggests Further Study of Peanut Tolerance with Oral Mucosal Immunotherapy (OMIT)

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Observer Falkland Islands

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.